why choose us

First received: January 25, 2023

Clinical Trial: Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neoplasms

Study Type: INTERVENTIONAL


Official Title: An Open-label, Multicenter Phase 1 Study to Characterize Safety, Tolerability, Preliminary Antitumor Activity and Pharmacokinetics of VIP236 Monotherapy in Subjects With Advanced Cancer

Brief Summary: Determine the safety, tolerability, and maximum tolerated dose (MTD) of IV administered VIP236 as monotherapy in patients with advanced solid tumor cancer

Read more